A mutation, GD-1, in the leucine operon imposed unusual growth characteristics upon a leucine auxotrophic strain bearing the leucine operator mutation, leu-500. The strain with the GD-I mutation was able to grow on a minimal salts medium when citrate was the sole carbon source, but required leucine when glucose was present. Tests with a large number of carbohydrates suggest that in the strain bearing the GD-I mutation the leucine biosynthetic enzymes are under catabolite repressor control. Recombination studies indicate that the GD-I mutation is a secondary alteration of the leucine operator at or very close to the site of the leu-500 mutation. Mutations at the supX locus (previously termed su leu 500 and located on the chromosome between the cysteine B and tryptophan gene clusters) result in elimination of the catabolite repression effect. The data are interpreted as an indication that the GD-1 and leu-SOO mutations alter the leucine operator with respect to its specificity of response to repressors. A similar phenomenon has been detected with respect to the leucine biosynthetic enzymes in Salmonella typhimurium. The leucine operon of S.
A mutation, GD-1, in the leucine operon imposed unusual growth characteristics upon a leucine auxotrophic strain bearing the leucine operator mutation, leu-500. The strain with the GD-I mutation was able to grow on a minimal salts medium when citrate was the sole carbon source, but required leucine when glucose was present. Tests with a large number of carbohydrates suggest that in the strain bearing the GD-I mutation the leucine biosynthetic enzymes are under catabolite repressor control. Recombination studies indicate that the GD-I mutation is a secondary alteration of the leucine operator at or very close to the site of the leu-500 mutation. Mutations at the supX locus (previously termed su leu 500 and located on the chromosome between the cysteine B and tryptophan gene clusters) result in elimination of the catabolite repression effect. The data are interpreted as an indication that the GD-1 and leu-SOO mutations alter the leucine operator with respect to its specificity of response to repressors.
The classical glucose effect, as originally described by Epps and Gale (4) and later by Monod (13) , was characterized by the ability of glucose to inhibit the synthesis of certain enzymes. Investigations by Mandelstam (9) and Neidhardt and Magasanik (15, 16) led Magasanik (8) to name one aspect of this effect catabolite repression. Under this designation, catabolite-repressible (glucose-repressible) enzymes are generally those which convert their substrates to intermediary metaboliteswhich the cell can obtain independently and more readily from some other substrate. Implicit in this description was the observation that only catabolic or degradative enzymes were affected. A possible exception was reported by Gorini and Gunderson (5) , who observed that both induction and repression of the arginine biosynthetic enzymes in Escherichia coli B occurred and attributed it to catabolite repression. A repression and induction effect on the arginine enzymes was also obtained by Ramaley and Bernlohr (17) with Bacillus licheniformis.
A similar phenomenon has been detected with respect to the leucine biosynthetic enzymes in Salmonella typhimurium. The leucine operon of S. typhimurium consists of a cluster of four genes (10) whose function is coordinately regulated (1) . The four genes and the enzymes for which they code are shown in Fig. 1 . Margolin had previously shown that a leucine auxotroph, leu-S00, was the result of an operator-negative mutation affecting the entire leucine operon in S. typhimurium. Mukai and Margolin (14) subsequently described unlinked suppressor mutations affecting the leucine auxotrophy imposed by the leu-500 mutation. Cells bearing these suppressor mutations gave rise to small leucine-independent colonies when a leu-500 culture was spread on minimal agar medium and incubated for 72 to 148 hr. The locus, supX (previously termed su leu 500), of the suppressor mutations on the S. typhimurium chromosome was found to map between the cysteine B and tryptophan gene clusters. Figure 2 is a diagram of the relative chromosomal positions of the various loci described above. The leu-500 mutation was interpreted as an ox mutation which resulted in the creation of a xenesthetic leucine operator (14) .
A few strains with apparent suppressor mutations of leu-500 were isolated on a medium con Bacterial strains. All bacteria used were derived from S. typhimurium strain LT2. The leucine operator mutant leu-500 was previously characterized (10) . The origin and location' of the supX (previously dlesignated,su leu 500) mutations which suppress the leucine auxotrophy imposed by the leu-500 mutation were described by Mukai and Margolin (14) . Strains bearing deletion mutations, supX31, supX33, and supX20, were used. More detailed descriptions of two of these, supX31 and supX33, were presented previously (11) . Phage-sensitive recombinant strains were obtained by use of a mutant phage strain for transductions (10) .
Media. Davis and Mingioli (3) medium was employed in both liquid and solid cultures but with citrate omitted except as specified in the descriptions of experiments. The liquid cultures were supplemented with the following amino acids, bases, and vitamins: thiamine (4 15 ,g of L-leucine per ml, an amount which provides approximately half maximal growth for leucine auxotrophs. Samples to be assayed for enzyme activity were removed at cell densities indicated in the Results. The densities were followed in a Klett-Summerson colorimeter with a no. 42 filter.
When the chemostat was employed, the growth chamber contained 500 ml of medium and the pumping rate was 90 ml/hr, with L-leucine as the limiting nutrient. The cells were grown initially on 15 Ag of L-leucine per ml until the leucine was exhausted. The pumping in of fresh medium from the reservoir was then begun. Concentrations of L-leucine in the reservoir are indicated in the descriptions of individual experiments.
Transductions. All transductions were carried out according to the procedures described by Margolin (10) , with the use of phage PLT22 described by Zinder and Lederberg (19) and its derivatives.
Enzyme assays. The ,-isopropylrnalate dehydrogenase was assayed according to Burns, Umbarger, and Gross (2), and the a-isopropylmalate isomerase was assayed by the method of Gross, Burns, and Umbarger (6) 
RESULTS
Origin and characteristics of strains bearing the GD-I mutation. During an investigation of suppressor mutations in the strain bearing the leucine Ox mutation, leu-500, a few were found which differed significantly from the previously described (14) supX suppressors. These unusual new suppressor strains were given the designation GD and one of them (GD-I) was investigated in detail. As shown in Table 1 , strain GD-I will grow on a minimal salts medium with citrate, maltose, 30 ,ug of L-leucine per ml. In effect, the presence of glucose, galactose, or mannitol imposed a leucine auxotrophy upon strain GD-I.
To investigate the basis of the sensitivity to these carbohydrates, synthesis of the leucine biosynthetic enzymes was examined. Strain GD-I was grown in an amino acid enriched medium containing only 15 ,ug of L-leucine per ml, an amount which is growth-limiting for leucine auxotrophs. There remained the possibility that the ability of strain GD-I to synthesize higher levels of leucine pathway enzymes in the presence of citrate was fortuitous, due, perhaps, to such properties of citrate as its ability to chelate metal ions. To disprove such explanations, the 3-isopropylmalate dehydrogenase was measured for cells grown with citrate alone or with citrate plus either glucose or galactose. The results (Table 3) indicate that glucose and galactose repress synthesis of the dehydrogenase even in the presence of citrate. This is typical of catabolite repression.
Chromosomal location of the GD-I mutation.
Initial genetic studies showed that the GD-I mutation was cotransducible with the arabinose genes and therefore closely linked to the leucine operon (10) . An attempt was made to recover, by recombination, the original leu-500 mutation, separated from the GD-I mutation. The wild-type strain was used as donor, and a strain bearing the markers ara9, leu-500 GD-I was used as recipient in transductions. Selection for introduction of the donor's ara+ allele was made on a medium supplemented with L-leucine. The ara+ transductant colonies were then tested for their phenotype with respect to the leucine requirement. Of 5,000 ara+ clones tested, all were either leucine prototrophs (leu+) or retained the phenotype indicative of the GD-I mutation (leucine auxotrophy in the pres- ence of glucose and leucine prototrophy when citrate was the carbon source). An essentially reciprocal transduction with an ara+ leu-500 GD-I donor and an ara9 recipient strain produced the same results from 3,200 ara+ transductant colonies. Our inability to obtain any recombinant clones with the leucine auxotrophy of the leu-500 mutation indicates that the GD-I mutation is either too close to the site of the leu-S00 mutation to be readily separated from it or that it is, in fact, a secondary alteration of the leu-500 site.
Effect of supX suppressor mutations upon the phenotype of the GD-I strain. Transductionmediated recombinant strains were obtained which bore the GD-I mutation plus a deletion mutation which had been selected as a suppressor of leu-500. The effects of three such suppressor mutations were tested: supX20, supX31, and supX33 (see Fig. 2 ). In all cases, the sensitivity to catabolite repression was absent. The strains grew as well upon a medium containing glucose as upon a medium containing citrate as the sole carbon source. This was confirmed by the lack of any significant difference in the specific activities of the f3-isopropylmalate dehydrogenase found for cultures grown on the two different carbon sources (Table 4 ). In contrast, the histidase enzyme levels were sharply repressed in the presence of glucose, indicating that the supX deletions did not interfere with glucose uptake.
As indicated in Table 4 , the dehydrogenase levels of the presumed GD-I supX recombinant strains were about the same as that found for leu-500 supX strains. To confirm the presence of the GD-I mutation in these recombinants, further transduction tests were made. Replacement of the supX deletions by the supX+ allele, via transductions with the use of a wild-type donor, resulted in a return to the original GD-I phenotype (leucine auxotrophy in the presence of glucose). Furthermore, the GD-I supX strains could be utilize arabinose) as the recipient. Tests of the recombinants receiving the donor's ara+ allele revealed the expected (about 45%) cotransduction frequency with the GD-I mutation, expressed as a leucine auxotrophy in the presence of glucose.
Occurrence of mutations to glucose resistance in the GD-I strain. Spreading samples of the GD-I strain on a minimal agar medium containing glucose, followed by incubation at 37 C for 3 to 5 days, resulted in the formation of large numbers of glucose-resistant colonies. These resistant mutant variants were given the designation GDR. By means of the same method employed by Mukai and Margolin (14) to map the suppressors of the leu-SOO mutation, it was possible to show that nearly all the GDR strains arose as a result of mutations closely linked to the cysB and trp genes, presumably at the supX locus. A few GDR strains were found in which the mutations leading to the glucose-resistant phenotype were not linked to the supX locus. One such mutation was associated with a requirement for vitamin B6, one with a requirement for B1, one with an arginine requirement, and several with no secondary requirements. Genetic mapping has not yet been attempted with these strains. One of the unmapped GDR strains (GDR-6) grew almost as well as wild type in the presence of glucose. As shown in Table  4 , the 3-isopropylmalate dehydrogenase specific activity was the same for glucose-and citrategrown cells, whereas histidase synthesis was repressed in the presence of glucose (not shown in Table 4 ). Table 4 presents a comparison of the dehydrogenase specific activities in glucose-and citrate-grown cells of the various strains discussed above. As controls, the wild-type strain LT2 and the leuA428 leucine auxotrophic strain are included. The cells were grown in the amino acidsupplemented liquid medium with 15 ,ug of Lleucine per ml plus either glucose or citrate. Only the GD-I mutant strain showed any difference in dehydrogenase specific activity between the glucose-and citrate-grown cells.
Alternative to the catabolite repressor hypothesis. Another possible explanation for the reduced specific activity levels of the leucine pathway enzymes in glucose-grown cells of the GD-i strain is that in the presence of glucose the leucine pool was depleted much more rapidly than when citrate was the carbon source. As the leucine became limiting under our experimental conditions, there might not have been enough available for newly derepressed synthesis ofthe leucine pathway enzymes. An attempt was made to test this by growing the GD-I strain in chemostat cultures with L-leucine supplements of 0, 2, and 6 ,ug/ml in the reservoir, and with glucose and citrate as sole carbon sources. As shown in Table 5 , the specific activity of the ,B-isopropylmalate dehydrogenase increased with increasing concentrations of L-leucine supplement. These results seemed to support the pool depletion explanation. On the other hand, if depleted leucine pools of glucose-grown cells strongly affect the synthesis of the leucine pathway enzymes in strains with low levels of these enzymes to begin with (such as GD-I), then one might expect to find such effects in other strains with low-level leucine enzymes (i.e., leu-500, GD-I supX, etc.). The data of Table  4 do not at all conform with this prediction.
There is an alternative explanation for the chemostat data of Table 5 . Glucose-resistant (GDR) mutants arise at a high frequency, as mentioned previously. With low concentrations of a The enzyme specific activity was determined for cells in the growth chamber after the volume had been replaced over a period of 4 (360 ml) and 12 (1,080 ml) hr.
b The concentration of L-leucine is that in the fresh medium reservoir of the chemostat. leucine being pumped into the chemostat growth chamber, the limited growth of the cells would allow for the continuing occurrence of new GDR mutations. In the presence of glucose, the GDR mutants, having higher levels of leucine pathway enzymes, would have a distinct growth advantage over the GD-I parental strain. The higher levels of dehydrogenase specific activity found in the leucine-supplemented chemostat cultures of Table  5 might represent the accumulation of very high frequencies of GDR cells rather than loss of apparent glucose sensitivity of the GD-I mutant strain. To examine this possibility, two chemostats, one containing glucose and the other citrate, were inoculated with strain GD-I. The reservoir medium contained 6 pg of L-leucine per ml. Samples were taken at 0, 4, 8, and 12 hr after pumping was begun. After appropriate dilutions, these were spread on minimal agar medium containing glucose, plus 0, 1, or 2 ,ug of L-leucine per ml. After 24 hr of incubation at 37 C, the numbers of GDR colonies were counted. There was a dramatic increase in numbers of GDR colonies with increasing time of growth in the samples from the glucose-containing chemostats. The number was at least 10' to 106 times greater than the number of GDR colonies produced by equivalent samples from the citrate-containing chemostat. Highest frequencies were obtained on the leucine-supplemented plates. It seems very possible, therefore, that the higher dehydrogenase levels of glucosegrown cells in chemostats supplemented with low levels of leucine do, in fact, result from the rapid increase in the percentage of GDR cells in the population.
DIscussioN
The above results lead us to believe that a mutation in the operator of the leucine operon has brought the synthesis of the leucine biosynthetic enzymes under catabolite repression control. Although we do not as yet have the means for setting up the more definitive cis-trans test, our evidence makes it seem likely that the GD mutation is indeed an alteration of the leucine operator.
Mukai and Margolin (14) proposed that the leu-SOO mutation was an Oxc mutation resulting in an altered specificity of the leucine operator such that it became xenesthetic (sensitive to a "foreign" repressor). They further proposed that the supX locus was the gene which controlled the formation of the "foreign" repressor. In view of our data, we would like to suggest that the previously postulated foreign repressor is a specific (but as yet unidentified) catabolite repressor. It would then follow that the leu-500 mutation produced an altered leucine operator which was extremely sensitive to the catabolite repressor product of supX and thus caused leucine auxotrophy under all conditions of growth. The GD mutations would have further altered the leucine operator, makcing it less sensitive to the repressor product of the supX locus. This would result in repression of the leucine operon only by metabolites manifesting the strongest catabolite repression effects. Finally, any mutation which inactivated the supX locus would eliminate the catabolite repression, just as we have found.
It is interesting to note that the leu-500 mutant strain was selected after treatment of a culture with 5-bromouracil and was among a group of mutations found to be reverted by 2-aminopurine (12) . This indicates that the leucine operator bearing the leu-SOO mutation differs from the wild-type operator by only a single pair of bases. This suggests that the specificities of the regulatory sites of action of the leucine operator and the operon upon which the supX repressor product normally acts do not differ greatly. We do not know whether this is an unusual case of similarity of two repressor receptor sites or whether the different specificities of most operators are determined by rather minor differences in nucleotide sequence. If the latter is true, then that part of repressor receptor sites which govern specificity may consist of relatively short nucleotide sequences. We should mention that we have been unable to revert the GD-I mutation to wild type, using many mutagenic agents.
